These data suggest that CDK13 editing also occurs in thyroid tissue and that, in accordance with the high A-to-I editing activity observed in thyroid cancer [7, 8], a higher editing rate of CDK13 is evident in tumor samples. The gene discussed is CDK13; the disease is thyroid cancer.